FDA approves IONSYS for patient-controlled postop pain: 4 key notes

The FDA approved IONSYS (fentanyl iontophoretic transdermal system) by The Medicines Company.

Advertisement

Here are four key notes:

1. IONSYS is the first needle-free, patient-controlled, pre-programmed fentanyl delivery system.

2. The medication is intended for the short-term management of acute postoperative pain in adult patients.

3. IONSYS allows patients recovering from surgery in the hospital to control their analgesic dosing by pushing a button to dispense fentanyl transdermally via an imperceptible electrical current as needed for pain.

4. IONSYS is not intended for home use.

More articles on anesthesia:
TeamHealth acquires Professional Anesthesia Service: 3 quick facts
ONC names Dr. Andrew Gettinger CMIO: 3 observations
House considers Medicare Access to Rural Anesthesiology Act — 3 important observations

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.